APP and Alzheimer disease: In addition, gefitinib prevents memory loss in an Aβ42-overexpressing Drosophila model and rescues memory impairment in APP/PS1 Tg mice, a model of AD, indicating that EGFR inhibition can potentially improve cognitive function (Wang et al., 2012).